$1800 | Single User
$2700 | Enterprise License

China Allicin Industry Overview, 2017-2021
[Published by CRI]

Published by CRI: 05 Sep 2016 | 40604 | In Stock

Introduction

Description

China is a world leading producer, consumer and exporter of garlic. Garlic planting is common with widespread production areas for the habit of eating garlic around China.

In recent years, the garlic industry develops rapidly and becomes local mainstay in areas such as Shandong, Jiangsu, Henan, Hebei, Yunnan and Sichuan. China garlic is exported to over 120 countries and areas with increasing varieties and 70% of the exported tea is red garlic especially those mid-end and low-end kinds between 4.5cm to 5cm or 4.5cm to 5.5cm. The total output volume of garlic was about 4.5 million tons to 5 million tons with an export of 1.65 million tons in 2015.

Allicin is a kind of organic sulfur compounds extracted from garlic bulbs and it also can be found in onions and other onion plants. According to some animal experiments and vitro tests, allicin possesses functions of antibiosis, antifungal, antiphlogosis, antioxidant, antithrombus, lowering blood pressure, balancing lipoprotein and preventing arteriosclerosis. Allicin is popular in developed countries with health care consciousness and leads to a global heat of garlic health products. At present, the allicin health product market is initiated with a positive prospect in China.

The present report obtains first hand information of China allicin market through researches. It provides information to investors concerning the market status, competition status and development trend of allicin for opportunities through analyzing raw materials, production and demand of allicin.

Through this report, readers can acquire the following information:

-Development Environment of Allicin Industry in China

-Development Status of Allicin Industry in China

-Key Enterprises and Their Operation Status of Allicin Industry in China

-Competition Status of Allicin Industry in China

-Major Driving Forces and Market Opportunities of Allicin Industry in China

-Risks and Challenges in Allicin Industry in China

-Price Trend of Raw Materials of Allicin in China

-Development Trend of Allicin Industry in China, 2017-2021

Table of Contents
for China Allicin Industry Overview, 2017-2021 [Published by CRI]

  • Table of Contents

    1 Overview of Allicin Industry

    1.1 Relevant Concepts

    1.1.1 Definition

    1.1.2 Classification

    1.1.3 Use Analysis

    1.2 Overview of Raw Material Market

    1.2.1 Analysis on Major Production Areas of Raw Materials

    1.2.2 Analysis on Supply and Demand Status of Raw Materials

    2 Overview of Allicin Market in China, 2011-2016

    2.1 Analysis on Allicin Supply in China

    2.1.1 Overview of Production Status

    2.1.2 Analysis on Production Volume

    2.1.3 Analysis on Production Trend

    2.1.4 Analysis on Price Trend

    2.2 Analysis on Allicin Consumption in China

    2.2.1 Analysis on Consumption Status

    2.2.2 Analysis on Domestic Consumption Size

    2.2.3 Analysis on Consumption Trend

    2.3 Analysis on Import and Export of Allicin in China

    2.4 Market Competition Status of Allicin

    2.4.1 Barriers to Entry

    2.4.2 Competition Structure of the Industry

    3 Analysis on Major Allicin Producers in China, 2013-2016

    3.1 Enterprise 1

    3.1.1 Enterprise Profile

    3.1.2 Production Status of Allicin

    3.2 Enterprise 2

    3.3 Enterprise 3

    3.4 Enterprise 4

    3.5 Enterprise 5

    4 Raw Material Costs and Product Prices of Allicin in China, 2013-2016

    4.1 Price Trend of Raw Materials of Allicin

    4.1.1 Price Trend of Garlic in China, 2013-2016

    4.1.2 Factors Influencing Garlic Price Trend

    4.2 Price Trend of Allicin in China, 2013-2016

    5 Recommendations on Development and Investment in China Allicin Market, 2017-2021

    5.1 Analysis on Factors Influencing Development of Allicin Industry in China

    5.1.1 Major Driving Forces and Market Opportunities in Allicin Industry in China

    5.1.2 Risks and Challenges in Allicin Industry in China

    5.2 Forecast on Supply and Demand in Allicin Industry in China

    5.3 Development Recommendations

    Selected Charts

    Chart Definitions Related to Allicin

    Chart Policies and Regulations Concerning Allicin

    Chart Analysis on Major Application Areas of Allicin

    Chart Analysis on Major Production Areas in China

    Chart Output Volume of Garlic in China, 2011-2016

    Chart Output Volume of Allicin in China, 2011-2016

    Chart Sales Revenue of Allicin in China, 2011-2016

    Chart Analysis on Price Trend of Allicin in China, 2013-2016

    Chart Price Trend of Garlic in China, 2013-2016

    Chart Forecast on Production Volume of Allicin in China, 2017-2021

Additional Details

Publisher

CRI

Publisher Information

CRI is a research and consulting company located in Shanghai, China, focusing on various industries and markets. It regularly produces a variety of market research reports, industry analytical reports publications covering 11 industries. It also provides customized industry research services for initial public offerings, corporate mergers and acquisitions, business development, market launch and financing for clients varying from private companies to the government entities. CRI has formed a series of methods and working ways in collecting data, analyzing facts & polices, establishing models and adapting the market.



Since 2007, CRI has established strategic cooperative relations with many institutions in the U.S.A., Canada, Australia, Hong Kong, etc. and gained abundant international resources as well as advanced research methods and strategic thinking.



Since 2008, CRI has integrated resources and begun providing investment consultation services for customers based on market research and oriented by international investment and domestic policies.



CRI also provides custom research. Since 2009, CRI has done more than 40 custom research projects serving IPO, corporate mergers and acquisition, business development, market launch, financing, etc. We provide flexible research services at reasonable cost. Our clients vary from private companies to governments.



CRI insists on the principles of independent research to win customers.



In the future, CRI will continue in-depth research on the development trends of Chinese market and even global market. CRI will provide services for customers adhering to the philosophy of high-efficiency, reliability, accuracy and concentration.

Reference

40604 | 1609394

Number of Pages

30

Report Format

PDF

CRI Reports

Related Reports

TitleDate PublishedPrice fromMore Details
China YCT International Group, Inc. (CYIG) - Financial and Strategic SWOT Analysis Review
SummaryChina YCT International Group Inc. (China YCT) is a pharmaceutical company. The company provi...
08 Nov 2015 by Global Data USD $300 More Info
China Biologic Products, Inc. (CBPO) - Financial and Strategic SWOT Analysis Review
SummaryChina Biologic Products, Inc. (CBP) is a plasma biopharmaceutical company that develops treat...
08 Nov 2015 by Global Data USD $300 More Info
China Resources Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic SWOT Analysis Review
SummaryChina Resources Wandong Medical Equipment Co., Ltd. (CR Wandong), a subsidiary of Beijing Pha...
08 Nov 2015 by Global Data USD $300 More Info
China Grand Pharmaceutical and Healthcare Holdings Limited (512) - Financial and Strategic SWOT Analysis Review
SummaryChina Grand Pharmaceutical and Healthcare Holdings Limited (China Grand) is a pharmaceutical ...
08 Nov 2015 by Global Data USD $300 More Info
Anxin-China Holdings Limited (1149) - Financial and Strategic SWOT Analysis Review
SummaryAnxin-China Holdings Limited. (Anxin-China) is a safety solution providing company that focus...
08 Nov 2015 by Global Data USD $300 More Info
China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review
SummaryChina Medical System Holdings Limited (CMS) is a pharmaceutical service provider that include...
08 Nov 2015 by Global Data USD $300 More Info
China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review
SummaryChina Shineway Pharmaceutical Group Limited (China Shineway), a subsidiary of Shineway Pharma...
08 Nov 2015 by Global Data USD $300 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
08 Nov 2015 by Global Data USD $300 More Info
Inside China’s Pharma Sales Force – insights from the frontline
IntroductionIn 2011, China’s pharmaceutical sales force exceeded that of the U.S. for the first time...
01 Jul 2013 by FirstWord Pharma USD $695 More Info
Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
01 Jun 2012 by FirstWord Pharma USD $995 More Info

This report is published by CRI

CRI is a research and consulting company located in Shanghai, China, focusing on various industries and markets. It regularly produces a variety of market research reports, industry analytical reports publications covering 11 industries. It also provides customized industry research services for initial public offerings, corporate mergers and acquisitions, business development, market launch and financing for clients varying from private companies to the government entities. CRI has formed a series of methods and working ways in collecting data, analyzing facts & polices, establishing models and adapting the market.

Since 2007, CRI has established strategic cooperative relations with many institutions in the U.S.A., Canada, Australia, Hong Kong, etc. and gained abundant international resources as well as advanced research methods and strategic thinking.

Since 2008, CRI has integrated resources and begun providing investment consultation services for customers based on market research and oriented by international investment and domestic policies.

CRI also provides custom research. Since 2009, CRI has done more than 40 custom research projects serving IPO, corporate mergers and acquisition, business development, market launch, financing, etc. We provide flexible research services at reasonable cost. Our clients vary from private companies to governments.

CRI insists on the principles of independent research to win customers.

In the future, CRI will continue in-depth research on the development trends of Chinese market and even global market. CRI will provide services for customers adhering to the philosophy of high-efficiency, reliability, accuracy and concentration.

Download Free Report Summary PDF

China Allicin Industry Overview, 2017-2021 [Published by CRI] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...